No Data
No Data
No Data
No Data
No Data
Express News | Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $8 Price Target
Moomoo 24/7Apr 10 06:58 ET
Strong Week for Verrica Pharmaceuticals (NASDAQ:VRCA) Shareholders Doesn't Alleviate Pain of Three-year Loss
Yahoo FinanceApr 3 07:36 ET
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
WEST CHESTER, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica") (NASDAQ:VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions,
GlobeNewswireApr 2 07:30 ET
Verrica Pharmaceuticals' Ycanth Gets New Chemical Entity Status, Orange Book Listing
Verrica Pharmaceuticals (VRCA) said Tuesday its lead product, Ycanth, has received New Chemical Entity status and a listing in the Orange Book from the US Food and Drug Administration. "While NCE stat
MT NewswiresMar 26 14:41 ET
Verrica Pharma Gains as FDA Lists Ycanth in Orange Book
Seeking AlphaMar 26 13:33 ET
Verrica Pharmaceuticals: YCANTH Granted NCE Status By FDA - Quick Facts
RTTNewsMar 26 08:10 ET
No Data
No Data
Salmon Klein : are you in here?
TrytosaveabitOP Salmon Klein: Waiting to see if getting permanent reimbursement coverage draws the market’s attention? GL
Salmon Klein TrytosaveabitOP: I have been in since last week... huge CEO purchases over last month, positive cash flow, hopping for a second run to 8?
TrytosaveabitOP Salmon Klein: Very nice! Yes if I was already in, I would be feeling pretty good about the chances of seeing a PI! I mean now it’s like guaranteed money for the company.
Salmon Klein TrytosaveabitOP: sorry again, PI? press something? hehehe
View more comments...